Study of Patient Satisfaction With the Cancer Clinical Trial Experience
The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.
The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Prospective
|Official Title:||Study of Patient Satisfaction With the Cancer Clinical Trial Experience|
- Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment. [ Time Frame: Survey will be sent to subject 3 months after study registration ] [ Designated as safety issue: No ]
|Study Start Date:||October 2008|
|Study Completion Date:||May 2012|
|Primary Completion Date:||May 2012 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00768976
|Principal Investigator:||Joyce Neading, RHIT, CTR||Summa Health System|